103-0022 E.T.S. Muromachi bldg. 10th floor, 3-3-1 Nihombashi-muromachi, Chuo-ku, Tokyo
Establishment
1st October 2010
Representative
President & CEO: Mr. Tetsuya Sugimoto
Capital
30 million Yen
Accounting period
March (Once in a year)
Number of Employees
62
Main Bank
Sumitomo Mitsui Banking Corporation
Shareholder
Senju Pharmaceutical Co., Ltd., etc
Business Details
Development and marketing of pharmaceutical products
Licensing, etc
Wholesale business license April 2011 acquisition
First and Second type, Pharmaceutical manufacturing and sales business license
Update: June 2016
History
年月
事項
Established CEOLIA Pharma Co.,Ltd., as a joint venture of ASKA Pharmaceutical Co., Ltd. and Senju Pharmaceutical Co., Ltd.
(Capital of 30 million yen, 2-5-1 Shibaura, Minato-ku, Tokyo)
Started promotional business of ENT-related medical drugs.
Head Office shifted to 3-3-1 Nihonbashi Muromachi Chuo-ku Tokyo
CEOLIA obtains permission of First-class and Second-class Marketing Authorization Holders
Opened Osaka sales offices in 1-8-29 Nishimiyahara Yodogawa-ku, Osaka-shi.
Opened Fukuoka sales office in 9-12 Shimokawabata-cho Hakata-ku, Fukuoka-shi.
Opened a Tokyo office in 1-1-32 Nihonbashi,Ningyo-cho Chuo-ku, Tokyo
Closure of Tokyo Office and establishment of new office in 4-3-16 Nihonbashimuromachi Chuo-ku, Tokyo
Opened a logistics warehouse in 47-1 Kiyohisa-cho Kuki-shi Saitama Prefecture .
Signed one hand sales contract with Takeda Pharmaceutical Company Limited and
(Start of the direct transactions with Takeda Pharmaceutical Company Limited)
Transfer of Kansai Sales Office to 3-1-9 Awaji-cho Chuo-ku, Osaka-shi.
